beta-adrenergic receptor blockade in chronic heart failure.
Bristow
M R
MR
Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO 80262, USA. Michael.Bristow@UCHSC.edu
D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017298:Bisoprolol / Q000493:pharmacokinetics / Q000627:therapeutic use; D002227:Carbazoles / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077261:Carvedilol; D002908:Chronic Disease; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006334:Heart Function Tests / Q000187:drug effects; D006801:Humans; D008790:Metoprolol / Q000493:pharmacokinetics / Q000627:therapeutic use; D011412:Propanolamines / Q000493:pharmacokinetics / Q000627:therapeutic use; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*; D015398:Signal Transduction
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; D000077261:Carvedilol; C024307:bucindolol; D008790:Metoprolol; D017298:Bisoprolol